Upsher-Smith announces generic Qudexy XR
MAPLE GROVE, Minn. — Upsher-Smith Labs on Monday announced the launch of topiramate extended-release capsules, an authorized generic version of Qudexy XR (topiramate) extended-release capsules. The drug is a once-a-day, broad-spectrum antiepileptic drug that's engineered to provide a smooth pharmacokinetic profile.
Both Qudexy XR and its generic equivalent may be swallowed whole or administered by opening the capsule and sprinkling the contents on a spoonful of soft food, the company said.
“At Upsher-Smith, we are breaking the traditional mold and making a generic equivalent to Qudexy XR available immediately so that clinicians and their patients have faster and more affordable access to our quality extended-release topiramate, which is manufactured using the same materials and process as the brand,” said Mark Evenstad, president and CEO of Upsher-Smith. “This launch reflects our commitment to simplify access to effective treatments and provide quality, high-value products to patients.”.
The branded and generic drug are available in 25-mg, 50-mg, 100-mg, 150-mg and 200-mg dosage strengths.
Study: Coupling injected polio vaccine with more commonly used live oral polio vaccine may eradicate disease
Lindt expands portfolio with Russell Stover deal
KANSAS CITY, Mo. — Lindt & Sprüngli Group announced on Monday that it has reached an agreement to purchase Russell Stover Candies. The Russel Stover and Whitman's brands will complement Lindt & Sprüngli's existing portfolio of premium chocolates, making it the No. 3 North American chocolate manufacturer, the company said.
"This biggest and most important strategic acquisition to date in Lindt & Sprüngli's history is a unique opportunity for us to expand our North American chocolate business and will greatly enhance the group's status in the world's biggest overall chocolate marketplace," said Ernst Tanner, chairman of the Lindt & Sprüngli board of directors and group CEO.
Russell Stover reports annual sales of close to $500 million and has been headquartered in Kansas City, Mo., for more than 80 years. In addition to four chocolate factories, the company runs a chain of 35 retail outlets, most of which are located in the central United States. The company will continue to maintain headquarters in Kansas City. Financial terms of the deal were not released by the company, but Reuters reported that it's around one billion dollars.